These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 12911565)
1. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565 [TBL] [Abstract][Full Text] [Related]
2. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project. Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035 [TBL] [Abstract][Full Text] [Related]
3. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR; J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-alpha dosage requirements in a provincial hemodialysis population: effect of switching from subcutaneous to intravenous administration. Raymond CB; Collins DM; Bernstein KN; Skwarchuk DE; Vercaigne LM Nephron Clin Pract; 2006; 102(3-4):c88-92. PubMed ID: 16282700 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive vision for intravenous iron therapy. Coyne DW Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257 [TBL] [Abstract][Full Text] [Related]
6. [Iron replacement in hemodialysis patients with a normal serum ferritin level]. Riedel MK; Morgenstern T Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Chavers BM; Roberts TL; Herzog CA; Collins AJ; St Peter WL Kidney Int; 2004 Jan; 65(1):266-73. PubMed ID: 14675059 [TBL] [Abstract][Full Text] [Related]
8. Current management of anemia in adult hemodialysis patients with end-stage renal disease. Frankenfield DL; Johnson CA Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Charytan C; Qunibi W; Bailie GR; Nephron Clin Pract; 2005; 100(3):c55-62. PubMed ID: 15824508 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis. Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416 [TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
12. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. Tonelli M; Blake PG; Muirhead N ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321 [TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
14. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Pisoni RL; Bragg-Gresham JL; Young EW; Akizawa T; Asano Y; Locatelli F; Bommer J; Cruz JM; Kerr PG; Mendelssohn DC; Held PJ; Port FK Am J Kidney Dis; 2004 Jul; 44(1):94-111. PubMed ID: 15211443 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis. De Palo T; Giordano M; Palumbo F; Bellantuono R; Messina G; Colella V; Caringella AD Pediatr Nephrol; 2004 Mar; 19(3):337-40. PubMed ID: 14745634 [TBL] [Abstract][Full Text] [Related]
16. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis. Anees M; Mumtaz A; Ibrahim M; Shaheen SM; Asghar A Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306 [TBL] [Abstract][Full Text] [Related]
17. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study. Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118 [TBL] [Abstract][Full Text] [Related]